Cancer vaccine production facilities extended

The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities.

Doubling its footprint in the Fleming Building to over 15,000 square feet, the company is investing in new laboratories and office space to meet growing demand for its services.

Alastair Hay, account manager, said: “Personalised cancer vaccines based on neo-antigenic peptides is an exciting new era for oncology, and our Technopole site already has the world’s first GMP-certified facility specifically for the production of these peptide vaccines for clinical trials. Around a quarter of our existing resources in Edinburgh are currently engaged in cancer vaccine production, and the entirety of the new space will be dedicated to this application.”

The expansion will provide a four-fold increase in the GMP manufacturing footprint, as well as supporting administrative space.

Alastair continued: “Having first moved to Edinburgh Technopole just a few years ago, we have been keen to further extend our footprint on site. Our main challenge in the rapidly developing field of personalised cancer vaccines is to stay ahead of global demand, and the new laboratories – together with a commensurate growth in our staff numbers – will help to ensure that we are well placed to achieve this.”  

Simon Hoad, executive director for Edinburgh Technopole, commented: “Edinburgh Technopole is proud to support Almac and its ground-breaking research into personalised cancer medicine, by providing the facilities for the world’s first GM-certified facility for peptide-based personalised cancer vaccines. We are committed to helping innovative and growing businesses through continued expansion, and have recently started the construction of three new buildings, as well as a new restaurant and collaboration areas. Each building will provide up to 20,000 square feet of additional laboratory and office space, and we expect to welcome the first tenants from Q2 2019.”


Other news

Upcoming Events

Knowlex Infection Prevention & Control 2019

The Brewery London
27th February 2019

Theatres and Decontamination Conference 2019 (NPAG)

Ricoh Arena
6th March

CSC Annual Scientific Meeting

Worsley Park Marriott Hotel and Country Club
1st and 2nd April

ebme 2019

Arena MK, Milton Keynes
3rd and 4th April 2019

BSA Annual Conference 2019: Translating Research into Practice

Molineux Stadium, Wolverhampton
Wednesday 5th June

Latest Issue

Clinical Services Journal

Clinical Services Journal

Feb 2019

The future of patient monitoring at Salford

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Dec 2018

‘Clean Between’ – renewing the focus on infection prevention

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.